Dashboard
Explore Stocks
Pricing
About
Sign Up
Summary
Intrinsic Value
Fundamental Analysis
Wall Street Estimates
Dividend Analysis
Competition
Ownership
News
Profile Summary
Financials
Income Statement
Balance Sheet
Cash Flow
DCF Valuation
Earnings Call
Dividends
Wall Street Estimates
Read Financial Reports
Stock Analysis Checklist
Erasca, Inc. ERAS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.24
6.9 %
$ 351 M
Market Cap
-1.8
P/E
Price Target
Average
367.74%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
--33.56%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Erasca, Inc.
Wall Street analysts predict an average 1-year price target for
ERAS
of
$5.8
, with forecasts ranging from a low of
$5
to a high of
$7
.
ERAS Lowest Price Target
Wall Street Target
5 USD
303.23%
ERAS Average Price Target
Wall Street Target
5.8 USD
367.74%
ERAS Highest Price Target
Wall Street Target
7 USD
464.52%
Price
Max Price Target
Min Price Target
Average Price Target
7
7
6
6
5
5
4
4
3
3
2
2
1
1
Jun '24
Jun '24
Jul '24
Jul '24
Aug '24
Aug '24
Oct '24
Oct '24
Nov '24
Nov '24
2025
2025
Feb '25
Feb '25
Apr '25
Apr '25
Jun '25
Jun '25
Jul '25
Jul '25
Aug '25
Aug '25
Oct '25
Oct '25
Nov '25
Nov '25
2026
2026
Feb '26
Feb '26
Apr '26
Apr '26
REVENUE FORECAST
Revenue Forecast Chart
ERAS
$180.0m
$180.0m
$160.0m
$160.0m
$140.0m
$140.0m
$120.0m
$120.0m
$100.0m
$100.0m
$80.0m
$80.0m
$60.0m
$60.0m
$40.0m
$40.0m
$20.0m
$20.0m
$0.0
$0.0
2023
2023
2024
2024
2025
2025
2026
2026
2027
2027
2028
2028
2029
2029
EBIT FORECAST
EBIT Forecast Chart
ERAS
$0.0
$0.0
($50.0m)
($50.0m)
($100.0m)
($100.0m)
($150.0m)
($150.0m)
($200.0m)
($200.0m)
($250.0m)
($250.0m)
2023
2023
2024
2024
2025
2025
2026
2026
2027
2027
2028
2028
2029
2029
NET INCOME FORECAST
Net Income Chart
ERAS
$0.0
$0.0
($200.0m)
($200.0m)
($400.0m)
($400.0m)
($600.0m)
($600.0m)
($800.0m)
($800.0m)
($1.0b)
($1.0b)
($1.2b)
($1.2b)
($1.4b)
($1.4b)
($1.6b)
($1.6b)
($1.8b)
($1.8b)
2023
2023
2024
2024
2025
2025
2026
2026
2027
2027
2028
2028
2029
2029
Upgrade a Plan
If you need more info, please check
Pricing Guidelines
.
Free
forever, no credit card required
$
0
/ Mon
Up to 3 Valuations Access per week
Only 1 Watchlist
Select
Unlimited Plan
No restrictions, no limits.All stocks, all tools.
$
15.00
/ month
All stocks, all tools.
No restrictions, no limits.
Select Plan
Premium Plan
Enough to check your investmentsfrom time to time.
$
9.00
/ month
15 stocks per week
Enough to check investments
Select Plan
Add Note
Capture your thoughts
Note
Sell
Buy
Hold
Pass